Background: HIV is associated with elevated markers of vascular remodeling that may contribute to arterial fibrosis and stiffening and changes in pulse pressure (PP). These changes may, in turn, deleteriously affect autoregulation of cerebral blood flow and neurocognitive function.
INTRODUCTION
HIV-associated neurocognitive impairment (NCI) remains highly prevalent in the current era of combination antiretroviral therapy (cART), 1 although the severity of impairment tends to be milder than in the pre-cART era. 1, 2 Even mild forms of NCI can be associated with poor everyday functioning. 3, 4 The burden of HIV-associated NCI is projected to increase as persons living with HIV (HIV+) age. 5 In addition, older age-related diseases that affect the general population, such as cardiovascular disease (CVD), are increasingly observed in HIV+ persons [6] [7] [8] and are anticipated to increase in the future. 7 With the increased incidence and prevalence of CVD, there is a growing body of evidence demonstrating the detrimental effect of CVD risk factors on neurocognitive function among HIV+ persons. [9] [10] [11] HIV disease, which is characterized by chronic inflammation, may confer risk for increased arterial stiffness. [12] [13] [14] [15] Arterial stiffening is a complex process involving structural and functional changes in the arterial wall that occurs with normal aging 16 and is accelerated by chronic inflammatory conditions, such as diabetes mellitus and hypertension. 17, 18 Arterial remodeling is influenced by multiple biological pathways, including vascular endothelial growth factor (VEGF) and angiopoietin pathways. 19 VEGF and angiopoietins are considered to work in concert during vascular remodeling, such that VEGF is expressed during the earliest stages of vascular remodeling and the angiopoietin pathway plays a larger role in vessel maturation. 20 With increased arterial stiffening, changes in blood pressure (BP) occur such that systolic BP (SBP) increases, diastolic BP (DBP) decreases, and pulse pressure (PP)-defined as the difference between SBP and DBP readings-increases. 16 PP is a surrogate marker of arterial stiffness, and elevation of PP is an independent risk factor for future cardiovascular events and cerebrovascular disease. [21] [22] [23] [24] [25] Markers of arterial stiffness are associated with neurocognitive performance and decline in relatively healthy middle-aged adults. 26, 27 On the other end of the spectrum, poor cerebral perfusion related to low PP is associated with increased risk of NCI. 28 The neurologic consequences of vascular remodeling and arterial stiffness in the context of chronic HIV disease remain unclear and warrant investigation. The first aim of this study is to examine the relation of vascular remodeling with neurocognitive function. Angiogenic growth factors were examined because of their role in vascular remodeling. 19, 29 Second, we aim to investigate the association of vascular remodeling with PP. We hypothesize that biomarkers associated with vascular remodeling will be related to greater PP. Lastly, we aim to evaluate the association between neurocognitive function and PP. We hypothesize that PP will have a quadratic relationship with neurocognitive function, such that lower and higher PP values (relative to sample mean PP) will be associated with worse neurocognitive function.
METHODS

Participants and Procedure
The present study included 72 HIV+ and 36 HIV2 community-dwelling older (ie, aged 50 and above) adults who participated in the California HIV/AIDS Research Program Successfully Aging Seniors with HIV study at the UCSD HIV Neurobehavioral Research Program. The study protocol was approved by the UCSD Institutional Review Board, and all participants provided written informed consent to participate. Inclusion criteria were (1) being at least 50 years of age, (2) being on cART (for HIV+ participants), and (3) having an undetectable plasma HIV viral load (,48 copies per milliliter for HIV+ participants). Exclusion criteria included a history of non-HIV-related neurologic disorders or any other known condition that might account for impaired neurocognitive function (eg, seizure disorder). Each participant underwent standardized neuropsychological, neuromedical, and psychiatric assessments.
Neurocognitive Assessment
Participants completed a comprehensive neurocognitive test battery (administration time: 2-2.5 hours) that assesses 7 neurocognitive domains consistent with Frascati recommendations for neuroAIDS research. 30 The 7 neurocognitive domains were speed of information processing (SIP), learning, memory, executive functioning, verbal fluency, working memory, and fine motor functioning (see Heaton et al 1 for details on the specific test battery). Raw scores from the neurocognitive tasks were converted to demographically adjusted T-scores (mean = 50, SD = 10 in healthy subjects) using the best available normative standards, which correct for the effects of age, education, sex, and ethnicity, as appropriate. 3, 31, 32 T-scores were further corrected for exposure to previous neurocognitive assessment, as needed. The demographically adjusted T-scores were averaged to derive a global T-score, the main outcome of interest in statistical analyses.
Neuromedical Assessment
Medical characterization of study participants included measurement of vital signs, anthropometrics, medical comorbidities, and current prescription medications. Blood was collected by venipuncture, and aliquots were stored at 280°C until assayed. BP was measured in the seated position with an automated sphygmomanometer. PP was calculated as the difference between SBP and DBP. Body mass index (BMI) was calculated from measured height and weight. Medical comorbidities and prescribed and over-the-counter medications were determined by interview.
For the HIV+ group, the following HIV disease characteristics were collected: AIDS diagnosis, estimated duration of HIV infection, current and nadir cluster of differentiation 4 (CD4) + T-cell counts, and duration of cART. HIV RNA level was measured in plasma by reverse transcriptase polymerase chain reaction (Abbott Diagnostics; lower limit of quantitation 48 copies per milliliter).
Biomarkers Related to Vascular Remodeling
Vascular remodeling-related biomarkers were measured in plasma by immunoassay: Angiopoietin 2 (Ang-2) (R&D Systems, Minneapolis, MN), VEGF, and endotheliumspecific receptor tyrosine kinase (Tie-2) (Meso Scale Discovery, Rockville, MD). Assays were performed in duplicate, and assays for the samples with coefficients of variation greater than 20% or outliers that were more than 4 SDs from the mean were repeated. Assays for 10% of the samples were also repeated to ensure operator and batch consistencies.
Psychiatric Assessments
Study participants underwent a comprehensive psychiatric research evaluation. The Composite International Diagnostic Interview, 33 a computer-assisted clinical interview, was administered. The Composite International Diagnostic Interview assesses the presence of lifetime and current affective disorders [eg, major depressive disorder (MDD)] and substance-use disorders using diagnostic criteria based on the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. 34 The Medical Outcome Study 36-Item Short-Form version 1.0 35 was used to assess physical functioning and emotional well-being.
Statistical Analyses
Comparison of demographic, medical, biomarker, psychiatric, and neuropsychological data across HIV+ and HIV2 groups was performed with 2-tailed t test or Pearson x 2 test, as appropriate. Biomarkers were log 10 transformed to reduce skewness as is standard practice. Pearson correlations for continuous variables and t tests for categorical variables were conducted between the dependent variables (DV) and explanatory variables (listed in Tables 1 and 2) to identify covariates to include in subsequent multivariable linear regression models (critical a = 0.10).
Three multivariable linear regression tests were conducted to examine the association between (1) biomarkers of vascular remodeling (independent variables, IV) and neurocognitive function (DV), (2) biomarkers of vascular remodeling (IV) and PP (DV), and (3) PP (IV) and neurocognitive function (DV). Given our objective to examine whether HIV moderates these relations, all multivariable linear regression analyses tested for HIV by IV interactions. Before final model selection, the variable inflation factor was used to check for multicollinearity among predictor variables, and model selection was rerun to include only one of the correlated variables at a time. To achieve parsimonious models, variables were only retained in the final models if they had P values ,0.10. All statistical tests were performed with JMP 11.0.0 (SAS, 2013).
RESULTS
Participants
The sample consisted of 108 participants who were predominantly middle-aged [mean 58.5 (SD 6.3) years] nonHispanic white (77.8%) men (76.9%) with some college education [mean 14.5 (SD 2.6) years]. Demographic, medical, and psychiatric characteristics of the sample are presented in Among the HIV+ participants (n = 72), the mean estimated duration of HIV infection was 17.3 years, the mean duration of exposure to cART was 11.9 years, the median current CD4 + T-cell count was 654 cells per cubic millimeter, and the median nadir CD4 + T-cell count was 180 cells per cubic millimeter. HIV disease-related characteristics of the HIV+ sample are presented in Table 2 .
HIV+ participants had worse neurocognitive function [global T-score = 45.8 (SD 7.0)] than HIV2 participants [global T-score = 49.9 (SD 6.4)] (P = 0.004). HIV+ and HIV2 participants had similar levels of plasma VEGF, Ang-2, and Tie-2 (P values for group differences . 0.05; Table 1 
Vascular Remodeling and Neurocognitive Function
At the univariable level, global T-scores did not have statistically significant correlations with the biomarkers of vascular remodeling: Ang-2 (r = 20.03, P = 0.77), Tie-2 (r , 0.01, P = 0.99), and VEGF (r = 20.10, P = 0.32). Multivariable linear regression analyses were conducted to test for potential interacting effects of HIV and biomarkers of vascular remodeling on neurocognitive function. Of the covariates listed in Tables 1 and 2 
Vascular Remodeling and PP
To examine empirically whether vascular remodeling was related to elevated PP, correlational analyses were performed in the entire sample (Table 4 ). Higher PP correlated with higher values of Tie-2 (r = 0.31, P , 0.01), but not VEGF (r = 0.10, P = 0.32) or Ang-2 (r = 0.03, P = 0.76). Multivariable linear regression analysis was performed to test for interacting effects of HIV and biomarkers of vascular remodeling on PP. Of the covariates listed in Tables  1 and 2 , age, BMI, dyslipidemia, hypertension, current smoker status, and nonsteroidal anti-inflammatory drug, antihypertensive, and lipid-lowering drug use were associated with PP (P values , 0.10). In the best fitting model (model adjusted R 2 = 0.24, P , 0.01; Table 3 , model 2), Tie-2 (b = 
PP and Neurocognitive Function
Multivariable linear regression with polynomial terms was used to determine the association between PP and neurocognitive function. It should be noted that although age was univariably associated with PP, it was not included in model 3 described above because we used demographically adjusted T-scores in our analyses. In post hoc analyses using non-age-adjusted global T-scores, age and both the linear and quadratic terms of PP were independently associated with neurocognitive function (data not presented).
In post hoc analyses, we examined the associations between vascular remodeling, PP, and neurocognitive function at the domain level by conducting multivariable linear regression analyses. Statistically significant models were obtained for fine motor functioning (model adjusted R 2 = 0.28, P , 0.001), SIP (model adjusted R 2 = 0.23, P = 0.001), executive functioning (model adjusted R 2 = 0.19, P = 0.01), and learning (model adjusted R 2 = 0.19, P = 0.01). The interaction of HIV and Tie-2 on neurocognitive function was statistically significant (P values , 0.05) in the models for fine motor functioning, SIP, and learning. The interaction of HIV and VEGF on neurocognitive function was statistically significant (P values , 0.05) in the models for fine motor functioning, SIP, and learning. Lastly, a statistically significant quadratic association between PP and neurocognitive function (P values , 0.05) was observed in the models for fine motor functioning, SIP, and executive functioning.
DISCUSSION
In our cohort of older HIV+ and HIV2 adults, markers of vascular remodeling and arterial stiffness were associated with neurocognitive function. HIV interacted with biomarkers of vascular remodeling (ie, Tie-2 and VEGF) on neurocognitive function. For HIV+ adults, lower Tie-2 values and higher VEGF values were associated with worse neurocognitive function. Vascular remodeling, as measured by higher Tie-2 values, was associated with greater PP values. In turn, PP had a quadratic relationship with neurocognitive function. Relative to the sample mean, lower and higher values of PP were associated with worse neurocognitive function. Together, these findings indicate that both vascular remodeling and altered cerebral blood flow autoregulation contribute to neurocognitive function. These effects seem to be driven by the neurocognitive domains of fine motor functioning, SIP, executive functioning, and learning.
Our investigation explored the association of angiogenic growth factors with both PP and neurocognitive function given their crucial role in vascular remodeling. 19, 29 A complex interplay of the angiopoietins, Tie-2, VEGF, and other pro-or antiangiogenic factors contribute to angiogenesis and vascular remodeling. 36 Angiopoietins bind to the endothelial tyrosine kinase receptor Tie-2 to exert contextdependent biological functions, 36 and circulating levels of Ang-2 and Tie-2 have been associated with CVD risk factors (eg, hypertension, diabetes mellitus, and abdominal obesity). 37 Ang-2 has previously been found to have a positive association with PP. 36 Our study did not find an association between PP and Ang-2; however, we found a positive association between PP and Tie-2. Given the cross-sectional design of this study, we are unable to infer whether this association reflects a dysregulation of VEGFs that contribute to microvascular rarefaction (ie, a deficiency in mature small vessels) 36 or PP-induced vascular remodeling. 36 Future research, particularly studies employing longitudinal designs, may tease apart the temporal association between vascular remodeling, PP, and cerebrovascular disease in the context of HIV disease. The interactions between vascular remodeling (ie, Tie-2 and VEGF) and HIV on neurocognitive function suggest that HIV is interacting with the aging brain to affect neurologic function. VEGF is generally considered to have neuroprotective effects, 38 whereas upregulated levels of Tie-2 may reflect pathological angiogenesis. 39 For HIV2 adults, we found that higher Tie-2 and lower VEGF values were associated with worse neurocognitive function. Counterintuitively, lower Tie-2 values and higher VEGF values were associated with worse neurocognitive function for HIV+ adults. One potential interpretation of these counterintuitive associations is that the neuroprotective effect of VEGF is attenuated within our HIV+ sample, given that they demonstrate good immunologic and virologic status. Emerging evidence indicates that the neuroprotective effect of VEGF may be the most robust among adults with greater risk factors for Alzheimer disease (AD). 38 It is possible that our HIV serostatus groups differ in regard to AD risk factors that, in turn, may be influencing the effect of VEGF on neurocognitive function. Alternatively, the association between lower Tie-2 values and worse neurocognitive function observed among the HIV+ sample may reflect pathological angiogenesis. Pathological angiogenesis shares many cellular and molecular processes with physiological angiogenesis (eg, sprouting of new blood vessels and recruitment of inflammatory cells to sites of inflammation); however, pathological angiogenesis is characterized by a highly disorganized vascular network. 39 Given that HIV is characterized by chronic inflammation, HIV+ adults may be particularly vulnerable to pathological angiogenic processes.
Despite not finding an interacting effect of HIV and PP on neurocognitive function, our results show an association between PP and neurocognitive function that holds in the overall sample. Arterial stiffness may lead to neurocognitive decline because of augmented pressure pulses that penetrate and cause damage to the smaller blood vessels of the brain. 40 Previous research indicates that cerebrovascular disease may be a key underpinning in HIV-associated NCI. 41 We found a quadratic association between PP and neurocognitive function. This is consistent with literature demonstrating a U-shaped relationship between PP and risk of AD and dementia, whereby both lower and higher ends of the PP spectrum confer risk. 28 Alternatively, the association between PP and neurocognitive function may reflect normal brain arterial aging. A recent histopathologic study showed that with age, the arteries of the brain undergo degenerative changes characterized by arterial thickening, even in the absence of atherosclerosis. 42 These degenerative changes are hypothesized to be the downstream effect of mechanical forces of blood flow. 42 Thus, it is possible that PP is indexing arterial stiffening that may be occurring in the periphery and brain.
Our sample of older HIV+ adults did not demonstrate different levels of arterial stiffness relative to older HIV2 adults. This finding is in agreement with studies finding no differences in arterial stiffness by HIV serostatus, 12 although there have been reports of increased arterial stiffness in the context of HIV. 43 Divergent results among studies may be related to differences in cohort characteristics. For example, among HIV+ persons, commonly reported determinants of arterial stiffness are low nadir CD4 T-cell counts (eg, ,350 cells per microliter), age, hypertension, and high cholesterol levels. [43] [44] [45] [46] [47] [48] [49] [50] [51] Given that our HIV+ sample demonstrated good immunologic and virologic status, potential effects of HIVrelated characteristics on PP may be greatly diminished. Discerning differences in PP among HIV+ adults on suppressive cART as compared with HIV2 adults requires careful selection of the appropriate HIV2 comparison group. 52 Our HIV+ and HIV2 samples were largely comparable across many characteristics (eg, age and prevalence of medical comorbidities and lifetime substance-use disorders). Thus, our failure to detect differences in PP may indicate that HIV+ persons do not have greater arterial stiffening when compared with an HIV2 sample with a comparable prevalence of comorbidities.
Consistent with previous studies involving older HIV+ adults, 10, 53 we found that diabetes mellitus emerged as an independent predictor of neurocognitive function. Diabetes mellitus has shown an association with NCI in HIV+ adults older than 55 years. 10 Likely mechanisms for the effect of diabetes mellitus on neurocognitive function may include direct damage to the brain from hyperglycemia, brain exposure to higher levels of glucose given disruption of the blood-brain barrier by HIV, 54 and/or increased risk for cerebral atherosclerosis. Imaging studies demonstrate an association between diabetes mellitus and morphological changes in the brain that are predominantly subcortical, which is similar to the subcortical effects of HIV. [55] [56] [57] Limitations of the study include its cross-sectional design and the high likelihood of selection bias, given that the parent study aimed to investigate "successful aging" with HIV and thus may have biased our sample toward a group of HIV+ patients demonstrating good immunologic and virologic profiles. Given our small sample size, we did not test whether the effect of vascular remodeling on neurocognitive function is mediated by PP given the likelihood of type II error. Our study collected resting BP rather than ambulatory BP, which may potentially demonstrate a different association with neurocognitive function or reveal differing BP profiles between HIV+ and HIV2 individuals. Our study used a proxy measure of arterial stiffness, whereas pulse wave analysis is a more direct and noninvasive method of assessing large artery or aortic stiffness. 58 Although vascular remodeling and PP were found to have associations with neurocognitive function, the clinical utility of these markers depends on the availability of efficacious treatments to reduce pathological angiogenesis and arterial stiffness and whether treatment-induced reductions of these processes translate to improved neurocognitive outcomes. 58 The etiology of HIV-associated NCI in the cART era is multifactorial and may be related to both direct and indirect consequences of HIV, the immune response, and comorbid factors, 59 such as subclinical CVD. Delineating the relative contribution of CVD risk factors, such as vascular remodeling and PP, in the pathogenesis of HIV-associated NCI may allow for the identification of adjunct therapies aimed at improving health outcomes for persons aging with HIV/AIDS.
